Feasibility study of finalizing the extended adjuvant temozolomide based on methionine positron emission tomography (Met-PET) findings in patients with glioblastoma.

MLA

Hirono, Seiichiro, et al. “Feasibility Study of Finalizing the Extended Adjuvant Temozolomide Based on Methionine Positron Emission Tomography (Met-PET) Findings in Patients with Glioblastoma.” Scientific Reports, vol. 9, no. 1, Nov. 2019, pp. 1–9. EBSCOhost, https://doi.org/10.1038/s41598-019-54398-2.

APA

Hirono, S., Hasegawa, Y., Sakaida, T., Uchino, Y., Hatano, K., & Iuchi, T. (2019). Feasibility study of finalizing the extended adjuvant temozolomide based on methionine positron emission tomography (Met-PET) findings in patients with glioblastoma. Scientific Reports, 9(1), 1–9. https://doi.org/10.1038/s41598-019-54398-2

Chicago

Hirono, Seiichiro, Yuzo Hasegawa, Tsukasa Sakaida, Yoshio Uchino, Kazuo Hatano, and Toshihiko Iuchi. 2019. “Feasibility Study of Finalizing the Extended Adjuvant Temozolomide Based on Methionine Positron Emission Tomography (Met-PET) Findings in Patients with Glioblastoma.” Scientific Reports 9 (1): 1–9. doi:10.1038/s41598-019-54398-2.